215
Views
4
CrossRef citations to date
0
Altmetric
Urology

Effects of short and long-term indapamide treatments on urinary calcium excretion in patients with calcium oxalate dihydrate urinary stone disease: A pilot study

, , , &
Pages 97-101 | Received 13 Sep 2011, Accepted 18 Nov 2011, Published online: 18 Jan 2012

References

  • Conte A, Genestar C, Grases F. Relation between calcium oxalate hydrate form found in renal calculi and some urinary parameters. Urol Int 1990;45:25–7.
  • Pierratos AE, Khalaff H, Cheng PT, Psihramis K, Jewett MA. Clinical and biochemical differences in patients with pure calcium oxalate monohydrate and calcium oxalate dihydrate kidney stones. J Urol 1994;151:571–4.
  • Grases F, Costa-Bauzá A, Ramis M, Montesinos V, Conte A. Recurrence of renal lithiasis. Scand J Urol Nephrol 2003;37:482–6.
  • Milliez P, Tcherdakoff P. Antihypertensive activity of a new agent, indapamide: a double-blind study. Curr Med Res Opin 1975;3:9–15.
  • Moore RA, Seki T, Ohsumi S, Oheim K, Kyncl J, Desnoyers P. Antihypertensive action of indapamide and review of pharmacology and toxicology. Curr Med Res Opin 1977;5:25–32.
  • Laubie M, Schmitt H. Comparison of the haemodynamic and autonomic effects of frusemide and indapamide, and localization of the natriuretic action of indapamide. Curr Med Res Opin 1977;5:89–100.
  • Onesti G, Pitone J, Lowenthal DL, Kim KE, Affrime M, Bronstein BJ, Studies on the natriuretic effect and site of action of indapamide. Curr Med Res Opin 1977;5:83–8.
  • Lemieux G, L'Homme C. Le traitement de l'hypertension arterielle par indapamide seul ou en association. Curr Med Res Opin 1983;8:235–40.
  • Lemieux G. Treatment of idiopathic hypercalciuria with indapamide. CMAJ 1986;135:119–21.
  • Borghi L, Elia G, Trapassi MR, Melloni E, Amato F, Barbarese F, Acute effect of indapamide on urine calcium excretion in nephrolithiasis and human essential hypertension. Pharmacology 1988;36:348–55.
  • Borghi L, Meschi T, Guerra A, Novarini A. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 1993;22:S78–86.
  • Ceylan K, Topal C, Erkoc R, Sayarlioglu H, Can S, Yilmaz Y, Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease. Ann Pharmacother 2005;39:1034–8.
  • Martins MC, Meyers AM, Whalley NA, Margolius LP, Buys ME. Indapamide (Natrilix): the agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuria. Br J Urol 1996;78:176–80.
  • Giusti A, Barone A, Pioli G, Girasole G, Siccardi V, Palummeri E, Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: a randomized controlled trial of two drugs and three treatments. Nephrol Dial Transplant 2009;24:1472–7.
  • Barr WG. Uric acid. In Walker HK, Hall WD, Hurst JW, editors. Clinical methods: the history, physical, and laboratory examinations. Boston, MA: Butterworth; 1990. p 770–2.
  • Costanzo LS, Weiner IM. On the calcium reducing action of chlorothiazide. J Clin Invest 1974;54:628–37.
  • Costanzo LS, Windhager EE. Calcium and sodium transport by the distal convoluted tubule of the rat. Am J Physiol Renal Physiol 1978;235:F492–506.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.